Professional Documents
Culture Documents
CNUR 204 - Unit Ten - Neurological Disorders
CNUR 204 - Unit Ten - Neurological Disorders
Neurological Problems:
● Seizure disorders and epilepsy
● Multiple sclerosis
● Parkinson’s
Seizures:
● Uncontrolled electrical discharge of neurons in the brain that interrupts normal function
● Can be provoked by an underlying cause/illness or due to an unknown cause
● Seizures resulting from systemic and metabolic disturbances are NOT epilepsy if the seizures cease when
the underlying problem is corrected.
Unprovoked Seizures:
● Some people have a single unprovoked seizure with no other cause and then never have another one
● 1/10 will experience a single unprovoked seizure in their lifetime
● NOT EPILEPSY
Epilepsy:
● A brain disorder in which a person is susceptible to having repeat seizures
● At least two spontaneous (unprovoked) seizures more than 24 hours apart (as 70-80% chance another
one will occur).
Possible Causes of Epilepsy:
● Anything that can injure the brain:
- Brain injury during birth
- Neurodegenerative disease
- Head injury
- Lack of oxygen
- Fetal alcohol syndrome
- Lead poisoning Carbon monoxide poisoning
- Meningitis
- Stroke
● A genetic mutation
● A developmental abnormality
● Idiopathic - Most common (not known)
● Whatever the cause, the neurons undergo spontaneous firing
Incidence of Epilepsy:
● The most frequent neurological condition (after migraine), affecting 1/100 people (about 300,000 people
in Canada).
● 75-80% are diagnosed before the age of 18.
● Can happen at any point in the lifespan but onset rates highest in the first year of life and increase again
among seniors.
Types of Seizures:
● Focal (Partial) Seizures:
- Begins within 1 hemisphere of the brain
● Generalized Seizures:
- Widespread seizure activity in both hemispheres of the brain
Phases of a Seizure:
1. Prodromal phase signs or activities that precede a seizure
2. Aural phase (sensory warning)
3. Ictal Phase (seizure activity)
4. Postictal Phase (period of recovery)
Generalized Seizures:
● Bilateral, synchronous epileptic discharges (affects the entire brain)
● No warning or aura
● Usually the patient loses consciousness
Myoclonic Seizures:
● Extremely brief (1 second)
● Sudden, excessive jerk of the body or extremities
Atonic Seizures:
● Sudden loss of muscle tone
● Causes the person to drop to the ground (“drop attack”)
● Great risk of Head injury
Tonic Seizures:
● Only involves the tonic phase (muscles stiffen)
● Can result in a “drop attack”, or arm stiffening
Clonic Seizures:
● Only involves the clonic phase (rhythmic jerking movements)
Collaborative Care
Treatment and Nursing Management - Ongoing Management:
● Drug therapy:
- Treated primarily with anti epilepsy medications
- Treatment is aimed at reducing the number of seizures but does not cure epilepsy
- Effectiveness:
- 50% of clients have seizure control
- 30% have a reduction in seizure intensity
- 30% have a reduction in intensity and frequency
- 20% have seizures which are resistant to medications (refractory epilepsy)
● Overall goal:
- Obtain maximum seizure control with minimal side effects (balancing act-need to figure out the
best dose for each individual client)
Emergency Situations:
● Emergency medical management should be sought if…
- The person does not have diagnosed epilepsy
- The seizure lasts longer than 5 minutes
- A second seizure occurs before the person has fully recovered from the first seizure (status
epilepticus)
- If regular breathing does not return when the seizure ends
- The person has diabetes (may be due to hypoglycemia)
- The seizure occurs in water
- If the person is pregnant
Dietary Management:
● Ketogenic Diet - most commonly used
● Medium chain triglyceride diet
● Modified Atkins diet
● Low glycemic index diet
Nursing Management
Treatment and Nursing Management During a Seizure:
● Ensure patent airway
● Remove or loosen clothing
● Turn the patient to one side
● MAY have to support the head if airway compromised
● Protect from injury:
- Do not restrain
- DO NOT place anything in mouth
- Side rail - padded/blanket
- Ease client into a lying position if sitting or standing
- Suction and oxygen if necessary
- Ensure IV access as soon as it is safe
- DO NOT try to stop the seizure
Etiology of MS:
● Cause is still unknown, research focuses on 4 possible causes:
- Genetic and biological predisposition
- Lifestyle and Environmental factors (Vitamin D, Obesity, smoking, viral infection with Epstein-Barr
virus)
Pathophysiology of MS:
● The disease attacks myelin, the protective covering of the nerves, causing inflammation and often
damaging the nerves
● Caused by autoreactive T cells (Lymphocytes):
- T cells normally cross the blood-brain barrier
- They are like a surveillance crew, their job is to check the CNS for antigens (something ‘foreign’)
and then leave.
- With MS, something triggers the presence of antigens in the CNS, and the T cells stay.
- The presence of T cells triggers an antigen-antibody response (activation of the inflammatory
response)
● This inflammation response leads to demyelination of axons
● Plaque is formed in place of the myelin (Gliosis)
● Myelin is necessary for the transmission of nerve impulses through nerve fibers. Nerve impulses travel
with minor interruptions with slight damage or completely disrupted if damage is substantial and if scar
tissue replaces myelin.
● Plaque formation in MS occurs primarily in optic nerves, white matter in the brain and spinal cord, the
brain stem, and cerebellum
Pathophysiology:
● Oligodendrocytes decrease:
- These are the cells in the CNS that produce myelin
● Astrocytes increase:
- Cells which aid in plaque formation in the brain (gliosis)
● Some remyelination can occur:
- In late 1990s it was discovered that myelin can regenerate (oligodendrocytes can reproduce)
- Some clients will have improvement of symptoms with remyelination
- However, remyelination must occur BEFORE the oligodendrocytes have died
- In the long run, it will not be sufficient to overcome the ongoing changes
- But this is why people will have “exacerbations” of MS
Categories of MS:
● Relapsing-Remitting:
- Unpredictable attacks which may or may not leave permanent deficits followed by periods of
remission
● Primary-Progressive:
- Steady increase in disability without attacks
● Secondary-Progressive:
- Initial relapsing-remitting multiple sclerosis that suddenly begins to have decline without periods
of remission.
● Progressive-Relapsing:
- Steady decline since onset with superimposed attacks
● Benign
Nutrition Therapy:
● Well balanced diet
● High protein:
- Helps with tissue repair
● Vitamin supplements
- Extra vitamin C can help keep urine acidic and decrease bacterial growth
● High roughage
● Vitamin D is recommended 800-4000 IU/day. This may help with slowing MS but also is good for bone
health.
● Several diets have been advocated for over the years (megavitamin therapies, raw food diet)
● Insufficient scientific evidence supports the effectiveness of these diet therapies
Physical Therapy:
● The overall goal of exercise and physical therapies is to decrease spasticity, increase coordination and
muscle strength, improve mobilization, gait, fatigue, and quality of life.
● Water exercises
● Stretching (pilates, yoga)
- Stretching minimizes joint contractures
● Assistive devices
● Balance rest/activity
Alternate Therapies:
● Surgery-neurectomy, rhizotomy, cordotomy for unmanaged spasticity/thalamotomy for unmanaged
tremor
● Nutritionist
● Megavitamin therapy
● Naturopathic remedies
● Chiropractic therapy
● Massage therapy
● Speech therapy
● Acupuncturist
● Cannabis
● Meditation
● Spirituality
● Share-write a blog, keep a diary, confide in a close friend, or attend therapy/support sessions
Parkinson’s Disease
Parkinson’s Disease Facts:
● 25 Canadians are diagnosed every day in Canada (100,000 Canadians living with Parkinson’s)
● More common in men than women (3:2 ratio)
● Average age of diagnosis is 60
● Symptoms usually appear in fifth decade of life
● Second most common neurodegenerative disease
Pathological Process:
● Degeneration of dopamine-producing neurons
● These neurons are located in the substantia nigra of the midbrain, which is:
- One part of the basal ganglia
- Contains cells that produce dopamine
- Dopamine is a neurotransmitter, which is essential for normal functioning of the extrapyramidal
motor system, including control of posture, support, and voluntary motion
● Results in dopamine depletion
● Symptoms do not occur until 80% of neurons in substantia nigra are lost
Clinical Manifestations:
● Insidious onset
● Gradual progression of symptoms
● Mild, early symptoms progress to more pronounced symptoms
● Early signs: mild tremor, slight limp and decreased arm swing
● Three cardinal manifestations (classic triad):
- Tremors
- Rigidity
- Bradykinesia (slowing down in the initiation and the execution of movement)
Other Manifestations:
● Cognitive decline
● Change in abstraction and judgment
● Slow thinking
● Decreased ability to form thoughts, to plan, to make decisions
● Memory loss
Complications of Parkinson’s:
● Neuropsychiatric problems - depression, anxiety, hallucinations
● Dementia can occur (40% of clients)
● Weakness and fatigue
● Masklike, expressionless face
● Sleep disturbances
● Speech and swallowing impairments
● Eczema skin changes - results from increase sweat glands activity
● Loss of smell
● As the disease progressed, complications increase:
- Worsening motor symptoms (dyskinesia, weakness, akinesia as well as swallowing difficulties -
dysphagia leading to malnutrition and aspiration)
- Worsening neurological symptoms (dementia)
- Worsening neuropsychiatric problems (depression, hallucinations, psychosis)
● General debilitation can lead to:
- Pneumonia
- UTI
- Constipation
- Skin breakdown
Diagnostic Studies:
● History of clinical features
● Firm diagnosis only when at least 2 of the 3 classic triad of symptoms is present
● Ultimate confirmation with a positive response to antiparkinsonism drugs
● Research ongoing - genetic testing/MRI
Drug Therapy:
● 3 main classifications to correct the imbalance of dopamine neurotransmitters in the CNS:
1. Stimulate dopamine (Dopaminergic)
- Carbidopa allows more Levodopa to get to the brain by preventing it from breaking
down in the blood.
- Levodopa turns into dopamine in the brain (Levodopa with carbidopa - Sinemet).
2. Dopamine Agonists: mimics or imitates actions of dopamine (Bromocriptine)
3. Block or antagonize the overproduction of cholinergic neurons in the striatum
- Anticholinergic - corrects imbalances between dopamine and acetylcholine (Cogentin).
Blocks the acetylcholine (The excitatory NT).
- Monoamine Oxidase Inhibitor - inhibits monoamine oxidase, the degradative enzyme of
dopamine - so enhances the effect of dopamine by preventing its breakdown.
● Symptom management:
1. Antihistamines with anticholinergic properties - to manage tremors:
- Benadryl
2. Beta-adrenergic blockers - to manage tremors:
- Propranolol
3. Antiviral - promotes the release of Dopamine from neurons:
- Amantadine
Surgical Therapy:
● Usually used for patients unresponsive to drug management or with severe complications
● Ablation therapy was used for 50 years - replaced now with:
● Deep Brain Stimulation:
- Procedure of choice
- Implanted electrode in brain and connected to generator implanted in chest, under skin like a
pacemaker
- Device delivers electrical impulses to stimulate the area of brain to increase neuronal activity and
aid in symptom control of PSD
● Transplantation of fetal neural tissue into the basal ganglia to provide dopamine producing cells:
- Only treatment that could potentially offer full functional restoration
● Stem cell research:
- Both epithelial and bone marrow cells are currently being studied
Nutritional Therapy:
● Adequate roughage and fruit
● Ample time for eating
● Smaller more frequent meals as less exhausting
● Absorption of Levodopa can be impaired by protein and vitamin B6
● Bradykinesia and dysphagia makes eating slow and can increase risk for choking/aspiration
- Assist to cut into bite size pieces
Nursing Management:
● Assist with ambulation/movement/mobility devices
● Consult physiotherapy/occupational/speech for assist with ADLs and Language Therapy prn
● Promotion of exercise
● Encourage independence in ADLs
● Safety - move slowly to help with balance, low heel without rubber sole, no scatter rugs
● Perform ROM:
- Avoidance of contractures
- Prevent pressure ulcers/wounds
- Prevent clots
- Prevent respiratory depression/infection
● Carefully monitor swallowing - risk for aspiration:
- Upright position to eat (during and 20 min after)
- Soft and easy to chew foods
● Optimize psychosocial well being:
- Difficulties with speaking, writing, loss of independence, frustration can lead to social withdrawal
and isolation